Categories: News

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Charlotte, North Carolina–(Newsfile Corp. – February 7, 2025) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation’s leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company’s December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.

CONFERENCE CALL DETAILS

Thursday, February 13, 2025, 4:20 p.m. Eastern Time
USA/Canada: 844-763-8274
International: 647-484-8814
Teleconference Replay dial in:
USA/Canada: 855-669-9658
International: 412-317-0088
Replay Passcode: 7970691
Webcast/Webcast Replay link – available through March 13, 2026:
https://www.gowebcasting.com/13965

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products, including NSF Certified for Sport® products, as well as our new Full Spectrum products. Our cbdMD brand currently includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including our Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our ATRx brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, or ATRxlabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD’s products.1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240114

Staff

Recent Posts

AsyncHealth launches Crowdfunding Campaign on StartEngine using Artificial Intelligence to Revolutionize Mental Health Care

AsyncHealth has a clinician-built platform that uses AI to streamline the delivery of mental health…

4 hours ago

Lyra Growth Partners Inc. Announces Sale of Common Shares of BuildDirect.com Technologies Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Lyra Growth Partners Inc. ("Lyra") announces…

8 hours ago

SCAN Named the Winner of the 2025 Hearst Health Prize

$100,000 Hearst Health Prize recognizes innovative initiatives using data science to make a health impact…

10 hours ago

Nanalysis Announces First Quarter 2025 Results

Delivers Another Quarter of Positive Adjusted EBITDA & Operating Cash Flow CALGARY, AB, May 28,…

10 hours ago

Veeva Announces Fiscal 2026 First Quarter Results

Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19%…

10 hours ago

Staffency, a TotalMed Company, Announces Merger with SimpliFi to Enhance Workforce Solutions

APPLETON, Wis., May 28, 2025 /PRNewswire/ -- Staffency, a premier workforce solutions provider and division…

10 hours ago